| ||||||
|
| ||||||
|
Micro-algal Technology In contrast to bacterial and yeast expression systems, which can be unsuitable for the expression of biological molecules for clinical use, due to inappropriate or lack of required downstream modifications, micro-algae can produce biomolecules that are equivalent to those produced by mammalian cells with regard to their biological activities and potential for clinical application. As production systems improve in efficiency and design and cost, the relative cost competitiveness and reliability of the algal production platform is expected to surpass that of existing platforms. Our Technology At present, our technology is in the pilot phase where we are rigorously testing our modification platform in multiple algal strains to determine the optimum conditions to achieve maximal results prior to the identification of industrial partners. Let us work with you to develop your desired strains and cut your development time. | ||||||
|